SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-10-001281
Filing Date
2010-11-15
Accepted
2010-11-15 13:45:58
Documents
5
Period of Report
2010-07-31

Document Format Files

Seq Description Document Type Size
1 lightlakethera10k073110.htm 10-K 615510
2 ex31-1.htm EX-31.1 11274
3 ex31-2.htm EX-31.2 11510
4 ex32-1.htm EX-32.1 6033
5 ex32-2.htm EX-32.2 5950
  Complete submission text file 0001185185-10-001281.txt   651766
Mailing Address 225-230 QUEENS QUAY W. TORONTO A6 M5J 2Y7
Business Address 225-230 QUEENS QUAY W. TORONTO A6 M5J 2Y7 416-841-5414
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 333-139915 | Film No.: 101191022
SIC: 1000 Metal Mining